Abstract
AbstractThe present work is a preliminary report of synthesis of a series of targeted 4,6‐O‐ethylidene‐β‐D‐glucopyranosylamine glycoconjugate quinoline 4‐carboxylic acid derivatives followed by a quick evaluation of their anti‐inflammatory and anticancer activities. Compounds C5 and C8 exhibited highest anti‐inflammatory activity against human COX‐2 enzyme. Anticancer studies were also performed in vitro which revealed C8 as a promising candidate against HeLa, human cervical cancer cell lines. The anti‐inflammatory and anticancer activity was further confirmed by molecular docking studies for all the synthesized molecules. That all the compounds showed potency, seems to validate our initial hypothesis concerning a positive correlation between anticancer and anti‐inflammatory activity for the designed quinoline glycoconjugates.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
